江苏亚虹医药科技股份有限公司关于公司董事会秘书正式履职的公告

Group 1 - The company has appointed Mr. Chen Baohua as the secretary of the board, pending the acquisition of the necessary training certification from the Shanghai Stock Exchange [1][2] - Mr. Chen has completed the required training and his qualifications have been submitted for record to the Shanghai Stock Exchange [2] - The company emphasizes the accuracy and completeness of the announcement, taking legal responsibility for its content [1] Group 2 - The company has submitted a medical device registration application for APLD-2304 to the EU notification body, which has been accepted [4][5] - APLD-2304 is a portable, single-use blue light bladder endoscope designed for bladder cancer diagnosis and monitoring, addressing a significant clinical need due to high recurrence rates of bladder cancer [6][7] - The product aims to improve detection rates of bladder cancer and reduce recurrence through its innovative design and technology [6][7]